BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 14997939)

  • 1. The genetic spectrum of human neuronal ceroid-lipofuscinoses.
    Mole SE
    Brain Pathol; 2004 Jan; 14(1):70-6. PubMed ID: 14997939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses.
    Mole SE; Williams RE; Goebel HH
    Neurogenetics; 2005 Sep; 6(3):107-26. PubMed ID: 15965709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [From gene to disease; from CLN1, CLN2 and CLN3 to neuronal ceroid lipofuscinosis].
    Taschner PE; Losekoot M; Breuning MH; Hofman I; van Diggelen OP
    Ned Tijdschr Geneeskd; 2005 Feb; 149(6):300-3. PubMed ID: 15730038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of the neuronal ceroid lipofuscinoses: mutations in CLN1, CLN2, CLN3, and CLN5.
    Mole SE; Mitchison HM; Munroe PB
    Hum Mutat; 1999; 14(3):199-215. PubMed ID: 10477428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular genetic basis of the neuronal ceroid lipofuscinoses.
    Gardiner RM
    Neurol Sci; 2000; 21(3 Suppl):S15-9. PubMed ID: 11073223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemistry of neuronal ceroid lipofuscinoses.
    Junaid MA; Pullarkat RK
    Adv Genet; 2001; 45():93-106. PubMed ID: 11332778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological and molecular characterization of neuronal ceroid lipofuscinosis in the Portuguese population.
    Teixeira C; Guimarães A; Bessa C; Ferreira MJ; Lopes L; Pinto E; Pinto R; Boustany RM; Sá Miranda MC; Ribeiro MG
    J Neurol; 2003 Jun; 250(6):661-7. PubMed ID: 12796825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of late-infantile neuronal ceroid lipofuscinosis.
    Zhong N; Moroziewicz DN; Ju W; Jurkiewicz A; Johnston L; Wisniewski KE; Brown WT
    Genet Med; 2000; 2(6):312-8. PubMed ID: 11339651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal ceroid lipofuscinoses: research update.
    Wisniewski KE; Kida E; Connell F; Zhong N
    Neurol Sci; 2000; 21(3 Suppl):S49-56. PubMed ID: 11073228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular pathology and pathogenic aspects of neuronal ceroid lipofuscinoses.
    Kida E; Golabek AA; Wisniewski KE
    Adv Genet; 2001; 45():35-68. PubMed ID: 11332776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuronal ceroid lipofuscinoses: mutations in different proteins result in similar disease.
    Weimer JM; Kriscenski-Perry E; Elshatory Y; Pearce DA
    Neuromolecular Med; 2002; 1(2):111-24. PubMed ID: 12025857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal ceroid lipofuscinoses caused by defects in soluble lysosomal enzymes (CLN1 and CLN2).
    Hofmann SL; Atashband A; Cho SK; Das AK; Gupta P; Lu JY
    Curr Mol Med; 2002 Aug; 2(5):423-37. PubMed ID: 12125808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal ceroid lipofuscinoses are connected at molecular level: interaction of CLN5 protein with CLN2 and CLN3.
    Vesa J; Chin MH; Oelgeschläger K; Isosomppi J; DellAngelica EC; Jalanko A; Peltonen L
    Mol Biol Cell; 2002 Jul; 13(7):2410-20. PubMed ID: 12134079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural and extraneural expression of the neuronal ceroid lipofuscinoses genes CLN1, CLN2, and CLN3: functional implications for CLN3.
    Chattopadhyay S; Pearce DA
    Mol Genet Metab; 2000; 71(1-2):207-11. PubMed ID: 11001812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse gene knockout models for the CLN2 and CLN3 forms of ceroid lipofuscinosis.
    Katz ML; Johnson GS
    Eur J Paediatr Neurol; 2001; 5 Suppl A():109-14. PubMed ID: 11588979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Australasian diagnostic service for the neuronal ceroid lipofuscinoses.
    Muller VJ; Paton BC; Fietz MJ
    Eur J Paediatr Neurol; 2001; 5 Suppl A():197-201. PubMed ID: 11588997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flupirtine blocks apoptosis in batten patient lymphoblasts and in human postmitotic CLN3- and CLN2-deficient neurons.
    Dhar S; Bitting RL; Rylova SN; Jansen PJ; Lockhart E; Koeberl DD; Amalfitano A; Boustany RM
    Ann Neurol; 2002 Apr; 51(4):448-66. PubMed ID: 11921051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Kufs' disease].
    Nagasato K
    Ryoikibetsu Shokogun Shirizu; 2002; (37 Pt 6):258-61. PubMed ID: 12483876
    [No Abstract]   [Full Text] [Related]  

  • 19. [Spielmeyer-Vogt-Sjögren disease].
    Saitoh S
    Ryoikibetsu Shokogun Shirizu; 2002; (37 Pt 6):255-7. PubMed ID: 12483875
    [No Abstract]   [Full Text] [Related]  

  • 20. Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses.
    Kousi M; Lehesjoki AE; Mole SE
    Hum Mutat; 2012 Jan; 33(1):42-63. PubMed ID: 21990111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.